Johnson & Johnson vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7
Buy
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $252.42 (+9.4%)
24 analysts
HOLD
Target $29.00 (+8.3%)
27 analysts
Fundamentals
JNJ
PFE
26.7×
Trailing P/E
19.7×
18.2×
Forward P/E
9.5×
21.8%
Profit Margin
12.4%
68.0%
Gross Margin
75.8%
26.4%
ROE
8.9%
9.9%
Revenue Growth
-1.2%
-52.9%
Earnings Growth
—
0.33
Beta
0.39
—
Price / Book
—
$555.5B
Market Cap
$152.3B
$146 – $252
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.